Kaleido Biosciences, Inc.KLDOOTCMARKET
Loading
R&D Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+17.3%
5Y CAGR+53.9%
Year-over-Year Change
Research and development spending
3Y CAGR
+17.3%/yr
Annual compound
5Y CAGR
+53.9%/yr
Recent deceleration
Percentile
P100
Near historical high
vs 5Y Ago
8.6x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2021 | $67.80M | +21.1% |
| 2020 | $55.97M | -12.9% |
| 2019 | $64.23M | +52.7% |
| 2018 | $42.06M | +100.4% |
| 2017 | $20.99M | +167.0% |
| 2016 | $7.86M | - |